AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency

被引：87

作者：

Kung, Charles ^{[1
]}

Hixon, Jeff ^{[1
]}

Kosinski, Penelope A. ^{[1
]}

Cianchetta, Giovanni ^{[1
]}

Histen, Gavin ^{[1
]}

Chen, Yue ^{[1
]}

Hill, Collin ^{[1
]}

Gross, Stefan ^{[1
]}

Si, Yaguang ^{[1
]}

Johnson, Kendall ^{[1
]}

DeLaBarre, Byron ^{[1
]}

Luo, Zhiyong ^{[2
]}

Gu, Zhiwei ^{[2
]}

Yao, Gui ^{[2
]}

Tang, Huachun ^{[2
]}

Fang, Cheng ^{[2
]}

Xu, Yingxia ^{[2
]}

Lv, Xiaobing ^{[2
]}

Biller, Scott ^{[1
]}

Su, Shin-San Michael ^{[1
]}

Yang, Hua ^{[1
]}

Popovici-Muller, Janeta ^{[1
]}

Salituro, Francesco ^{[1
]}

Silverman, Lee ^{[1
]}

Dang, Lenny ^{[1
]}

机构：

[1] Agios Pharmaceut Inc, Cambridge, MA USA

[2] Shanghai ChemPartner Co Ltd, Shanghai, Peoples R China

来源：

BLOOD | 2017年 / 130卷 / 11期

关键词：

NONSPHEROCYTIC HEMOLYTIC-ANEMIA; PK-LR GENE; RIBOFLAVIN TREATMENT; STEM-CELLS; ERYTHROCYTE; GENERATION; CANCER; ENZYME; MUTANT;

D O I：

10.1182/blood-2016-11-753525

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pyruvate kinase (PK) deficiency is a rare genetic disease that causes chronic hemolytic anemia. There are currently no targeted therapies for PK deficiency. Here, we describe the identification and characterization of AG-348, an allosteric activator of PK that is currently in clinical trials for the treatment of PK deficiency. We demonstrate that AG-348 can increase the activity of wild-type and mutant PK enzymes in biochemical assays and in patient red blood cells treated ex vivo. These data illustrate the potential for AG-348 to restore the glycolytic pathway activity in patients with PK deficiency and ultimately lead to clinical benefit.

引用

页码：1347 / 1356

页数：10

共 50 条

[21] RHEOLOGICAL PROPERTIES OF RED-BLOOD-CELLS IN PYRUVATE-KINASE DEFICIENCY
JACOBASCH, G
MEGOW, D
HOLZHUTTER, HG
STUDIA BIOPHYSICA, 1982, 90 : 115 - 117
[22] Increased levels of pyruvate kinase (PK) antigen in red blood cells of patients with pk deficiency
van Oirschot, Brigitte A.
van Solinge, Wouter W.
van Wijk, Richard
CLINICAL BIOCHEMISTRY, 2009, 42 (18) : 1859 - 1859
[23] Targeting the red cell enzyme pyruvate kinase with a small allosteric molecule AG-348 may correct underlying pathology of a glycolytic enzymopathy
Alayash, Abdu I.
HAEMATOLOGICA, 2021, 106 (01) : 9 - 11
[24] A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease
Xu, Julia Z.
Conrey, Anna
Frey, Ingrid
Gwaabe, Eveline
Menapace, Laurel A.
Tumburu, Laxminath
Lundt, Maureen
Lequang, Timothy
Li, Quan
Glass, Kristen
Dunkelberger, Emily B.
Iyer, Varsha
Mangus, Heidi
Kung, Charles
Dang, Lenny
Kosinski, Penelope A.
Hawkins, Peter
Jeffries, Neal
Eaton, William A.
Thein, Swee Lay
BLOOD, 2022, 140 (19) : 2053 - 2062
[25] THE PYRUVATE KINASE ACTIVATOR AG-348 IMPROVES MURINE B-THALASSEMIC ANEMIA AND CORRECTS INEFFECTIVE ERYTHROPOIESIS
Matte, A.
Beneduce, E.
Siciliano, A.
Kosinski, P.
Janin, A.
Lebouef, C.
Iolascon, A.
de Falco, L.
Dang, L.
Kung, C.
De Franceschi, L.
HAEMATOLOGICA, 2016, 101 : 18 - 18
[26] AG-348 (mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and adenosine triphosphate levels over a broad range of PKLR genotypes
Rab, Minke A. E.
van Oirschot, Brigitte A.
Kosinski, Penelope A.
Hixon, Jeffrey
Johnson, Kendall
Chubukov, Victor
Dang, Lenny
Pasterkamp, Gerard
van Straaten, Stephanie
van Solinge, Wouter W.
van Beers, Eduard J.
Kung, Charles
van Wijk, Richard
HAEMATOLOGICA, 2021, 106 (01) : 238 - 249
[27] EX VIVO TREATMENT OF RED BLOOD CELLS FROM 15 PYRUVATE KINASE (PK)-DEFICIENT PATIENTS WITH AG-348, AN ALLOSTERIC ACTIVATOR OF PK-R, INCREASES ENZYMATIC ACTIVITY, PROTEIN STABILITY AND ATP LEVELS.
van Oirschot, B.
Kosinski, P. A.
Hixon, J.
Johnson, K.
Chubukov, V.
Dang, L.
Pasterkamp, G.
van Straaten, S.
Kung, C.
van Wijk, R.
HAEMATOLOGICA, 2017, 102 : 241 - 242
[28] ELEVATED PYRUVATE-KINASE ACTIVITY IN PATIENTS WITH HEMOLYTIC-ANEMIA DUE TO RED-CELL PYRUVATE-KINASE DEFICIENCY
BEUTLER, E
FORMAN, L
RIOSLARRAIN, E
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (05): : 899 - 904
[29] MEMBRANE-LOCALIZED PYRUVATE-KINASE OF RED BLOOD-CELLS IN HEMOLYTIC-ANEMIA ASSOCIATED WITH PYRUVATE-KINASE DEFICIENCY
SCHROTER, W
TILLMANN, W
KLINISCHE WOCHENSCHRIFT, 1975, 53 (23): : 1101 - 1106
[30] INVESTIGATIONS OF KINETICS OF RED CELL PYRUVATE KINASE IN NORMAL INDIVIDUALS AND IN A PATIENT WITH PYRUVATE KINASE DEFICIENCY
WIESMANN, U
TONZ, O
NATURE, 1966, 209 (5023) : 612 - &

← 1 2 3 4 5 →